Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.81441 | 93 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.91541 | 93 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.08732 | 94 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.85795 | 92 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 7.7473 | 92 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.8669 | 94 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 8.00389 | 94 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.85759 | 93 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.95757 | 94 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.84533 | 93 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.88048 | 93 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.01165 | 93 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 8.01043 | 94 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.85047 | 93 |